Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Davendra P. S. Sohal, MD MPH, Nicole M. Kuderer, MD, Frances A. Shepherd, MD FRCPC, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Gary H. Lyman, MD MPH, Alok A. Khorana, MD

Blood (2016) 128 (22): 1422.

https://doi.org/10.1182/blood.V128.22.1422.1422

Published: 2016

Journal Articles

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Nicole M. Kuderer, MD, Marek S. Poniewierski, MD MS, MS, Eva Culakova, PhD MS, Gary H. Lyman, MD MPH, Alok A. Khorana, MD, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Frances A. Shepherd, MD FRCPC

Blood (2016) 128 (22): 3590.

https://doi.org/10.1182/blood.V128.22.3590.3590

Published: 2016

Journal Articles

Life-Threatening Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Effective Treatment with Eculizumab Followed By Rituximab

Ilene C Weitz, MD, Mark Boonyasampant, MD, Brian Kay, MD, Chaiyaporn Boonchalervichian, MD, Howard A. Liebman, MA, MD, Ira A. Shulman, MD

Blood (2014) 124 (21): 4286.

https://doi.org/10.1182/blood.V124.21.4286.4286

Published: 2014

Journal Articles

Phase I/II Study of Monotherapy with Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia

Howard A. Liebman, MA, MD, Mansoor N Saleh, MD, James B. Bussel, MD, O George Negrea, MD, Heather Horne, William Wegener, MD, PhD, David M Goldenberg, ScD, MD

Blood (2012) 120 (21): 622.

https://doi.org/10.1182/blood.V120.21.622.622

Published: 2012

Journal Articles

Thyroid Disorder-Related Immune Thrombocytopenia: Clinical and Laboratory Characteristics

Eric M. Cheung, DO, Rahul Naik, MD, Michael Keng, MD, Howard A. Liebman, MA, MD

Blood (2008) 112 (11): 4561.

https://doi.org/10.1182/blood.V112.11.4561.4561

Published: 2008

Journal Articles

Low-Dose Humanized Anti-CD20 Monoclonal Antibody (MAb), Veltuzumab, in Adult Immune Thrombocytopenic Purpura (ITP): Initial Results of a Phase I/II Study.

Howard A. Liebman, MA, MD, Mansoor N. Saleh, MD, Rashid Abassi, MD, Thomas M. Cosgriff, MD, Nick Teoh, PhD, Matthew J Leoni, MD, William Wegener, MD, PhD, David M Goldenberg, ScD, MD

Blood (2008) 112 (11): 3412.

https://doi.org/10.1182/blood.V112.11.3412.3412

Published: 2008

Journal Articles

Development of Venous Thromboembolic Events in Cancer Patients with Elevated Levels of Tissue Factor-Bearing Microparticles

Jeffrey Zwicker, M.D., Howard A. Liebman, MA, MD, Donna Neuberg, ScD, Kenneth Bauer, M.D., Furie Barbara, PhD, Furie Bruce, M.D.

Blood (2008) 112 (11): 3832.

https://doi.org/10.1182/blood.V112.11.3832.3832

Published: 2008

NARROW

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Life-Threatening Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Effective Treatment with Eculizumab Followed By Rituximab

Phase I/II Study of Monotherapy with Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia

Thyroid Disorder-Related Immune Thrombocytopenia: Clinical and Laboratory Characteristics

Low-Dose Humanized Anti-CD20 Monoclonal Antibody (MAb), Veltuzumab, in Adult Immune Thrombocytopenic Purpura (ITP): Initial Results of a Phase I/II Study.

Development of Venous Thromboembolic Events in Cancer Patients with Elevated Levels of Tissue Factor-Bearing Microparticles

Email alerts

ASH Publications

American Society of Hematology

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Life-Threatening Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Effective Treatment with Eculizumab Followed By Rituximab

Phase I/II Study of Monotherapy with Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia

Thyroid Disorder-Related Immune Thrombocytopenia: Clinical and Laboratory Characteristics

Low-Dose Humanized Anti-CD20 Monoclonal Antibody (MAb), Veltuzumab, in Adult Immune Thrombocytopenic Purpura (ITP): Initial Results of a Phase I/II Study.

Development of Venous Thromboembolic Events in Cancer Patients with Elevated Levels of Tissue Factor-Bearing Microparticles

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only